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Introduction
The existence of an increase in differences between 
subjects for many biological, sociological and psycho­
logical parameters with age is a widespread belief in 
gerontology [1-6]. Both theoretical arguments and 
empirical studies support this hypothesis [1, 7]. By 
analogy with the increase in variability between age 
groups in many psychological and biological para­
meters, a similar increase in variability in biomedical 
and pathophysiological parameters with age is com­
monly assumed.
There are solid reasons for such an assumption. 
Firstly, there is the fact that atypical presentation of 
illnesses occurs very frequently in elderly people, a
gerontology. In the present paper we report the level 
of attention paid to dispersion measures in recently 
published geriatric studies. We also studied whether 
sufficient data were reported to test the generally 
accepted age-related increase in variability between  
subjects in the biomedical outcome parameters
r t  w *
Methods
Many terms are used in the description of the 
distribution width of a data set. However, although 
they are very important in statistical analysis, there are 
no clear definitions of commonly used terms such as
widely accepted principle in geriatric medicine. This heterogeneity, diversity, dispersion, variability, varia-
individualization in presenting symptoms should result 
in a greater within-group variability in symptoms in 
older age groups compared with younger patients with 
the same disease. Secondly, just as ageing occurs at 
individual rates, the progression of degenerative ill­
nesses may be highly individual, The highly individual 
nature that this implies for degenerative diseases has 
been described for Alzheimer’s disease [8], Finally 
geriatric patients characteristically suffer from multiple 
diseases and impairments at the same time— and each 
individual will show a different combination and severity 
of problems, In their famous article on human ageing, 
Rowe and Kahn stress the importance of a differential 
approach to the diversity of the ageing population [9]. It 
seems logical to apply such a differential approach also to 
research on geriatric patients.
However, the effect of age on variability within age- 
groups is much less studied in medical gerontology 
than in the sociological and psychological domains of
tion and spread. ‘Heterogeneity’, ‘diversity’, 'variation1 
and ‘spread1 will not be used in the present report 
because they are often used in everyday language, and 
in other contexts. In this study 'dispersion’ refers to 
the distribution width of a parameter; ‘dispersion 
measures’ (DMs) are defined as all possible measures 
that can be used to quantify the width of a distribution. 
For numerical data, the most important DMs are: 
standard deviations (SDs)— and variances; coefficients 
of variation (CVs); ranges; and percentiles. The term 
‘variability’ can be used unequivocally in statistics only 
as a part of a compound. It can be defined as 
differences between measurements carried out at the 
same time or change in measurements with time. In 
biomedical research, variability can generally be 
divided into a biological, an analytical (measurement 
error) and a temporal component, Intra-individual 
variability, betweetvgroup variability and within-group 
variability (WGV) are essentially different. In this study,
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only WGV will be discussed. Homeoscedasticity and 
heteroscedasticity are the statistical terms that describe 
equality and unequality in dispersion, respectively,
Article selection
The four journals with the highest ‘impact factor* in the 
subject category listing Geriatrics & Gerontology of the
1993 Citation Index were selected for this study [10], 
These journals are: Journal of the American Geriatrics 
Society, Journal of Gerontology, Mechanisms o f  
Ageing and Development and Age and Ageing. From 
the Journal of Gerontology only the Medical Sciences 
section was included. We reviewed volumes 1993 and
1994 of these journals and selected all articles 
presenting empirical data. Animal and case studies 
were excluded.
For each article we recorded: (1) the type of 
research; (2) the number of subjects, their mean age 
and, if present, standard deviations of age and age 
ranges; (3) the type and number o f age-dependent 
outcome variables; (4) the presence, type and discus­
sion of DMs; (5) the presence of a discussion of WGV; 
(6) the presence of the keyword ‘variability* in the title 
or abstract.
Statistical analysis of W G V
The F-test of variance ratios (FViU.: ratio of older/ 
younger variance) was selected to test WGV between  
age groups. Data required for this F-test are: the 
number of younger and elderly subjects and the SD. 
Standard errors of the mean (SEM) or confidence 
intervals (Cl) could also be used after transformation to 
SD. The parametric /"-test was chosen despite its only 
moderate power as without the original data, there is 
no better way of testing WGV WGV can be con­
founded by differences in variable means for different 
age groups. For this reason, an analogous F-test for the 
ratios of the squared CVs (Fcv) for the older and 
younger group was performed. A two-sided signifi­
cance level of 0,05 was chosen for these F-tests. As well 
as judging each individual study for the possibility of 
performing these F-tests, we aimed to produce an 
overall analysis of WGV This analysis was executed by 
the so-called vote-counting technique: summing sig­
nificant and nonsignificant F-ratios within age groups 
[11]. In the case of an interventional study, F-tests were 
performed on baseline data and post-intervention data 
of the outcome variables. Only patient characteristics 
that were not directly related to the outcome variables, 
such as anthropometric measures, were not included 
in the analysis of WGV.
Additionally, a weighted analysis of WGV was 
performed by giving greater weight to those studies 
with larger sample size. This method was also applied 
by Devoider in her meta-analysis of WGV in memory 
functions [12]. The weight (iv) of individual studies’
F-ratios was calculated by comparing the number of 
younger (n {) and elderly (n>) subjects of an 
individual study with the total number of subjects 
(AO in all selected studies according to the formula
w  =  [wj x n2l(ri\ +  ni)]IN.
Each F-ratio was then multiplied by this weight and so, 
after summation, weighted overall F-ratios for vari­
ances and CV could be obtained (FWtViir and FWtCV 
respectively).
Criteria for inclusion
Differences in WGV in biomedical variables between 
different age groups could only be analysed in this way 
if the studies fulfilled the criteria presented in Table 1. 
F-tests could only be performed in cross-sectional 
studies since in longitudinal studies the subsequent 
measurements in the same individuals at different ages 
are not independent and the original data would be 
necessary to test an increase in WGV with age. Studies 
were also excluded when only psychological, socio­
logical or demographic outcome variables were 
measured because w e wanted to focus on biomedical 
or functional performance variables. Functional per­
formance variables were defined as variables measur­
ing performance at subject level (mobility, continence, 
cognition and performance of activities of daily living). 
This type of variable was included because of the 
importance of functional assessment in geriatrics.
There were a number of statistical prerequisites to 
allow application of F-tests. Firstly, F-tests require the 
presence of DMs (SD, SEM or Cl) of normally 
distributed data. To be meaningful, these DMs should 
address data measured quantitatively rather than on 
ordinal or nominal measurement scales. Furthermore, 
the DMs has to be present for age groups older and 
younger than 65 years. To exclude the confounding of 
WGV in the younger subjects by growth and develop­
ment, the youngest subject had to be older than 
20 years. A larger WGV in age in one of the groups 
(mostly the older age group) may be a cause of 
differences in WGV in the age-dependent variables. For 
this reason F-tests were not performed in cases where 
there were large differences in WGV in age (arbitrarily a 
factor of 2 was chosen). Studies were also excluded if a 
substantial ceiling effect in the age-dependent variables 
was likely This effect may occur especially in scales for 
functional assessment. The WGV for the younger age 
group is likely to be much smaller in these cases 
because most of the younger subjects have maximum 
scores.
Results
ire were 586 articles in which empirical data were 
presented. Only 76 studies (13%) focussed on elderly 
patients under the care of geriatricians. Mostly, patients
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Table I. Criteria used to judge whether age-related
differences in within-group variability in recently 
published biomedical outcome variables could be 
tested with /'-ratio tests
Table 2. Characterization of the 586 biomedical studies 
on ageing included in this review
Presence of empirical data 
Cross-sectional study design
Inclusion of outcome variables other than psychological/ 
sociological/demographic ones 
Presence of within-group variability for different age groups 
(i.e. SD, SEM, Cl)
Numerical data available 
Mean age of elderly subjeels > 65 years 
Minimum age of younger subjects > 20 years, mean age 
<65 years 
Number of subjects > 5
Standard deviations of ages or age-ranges not more than twice 
as large for elderly or younger subjects 
No ceiling effect in outcome variables 
Presence of details of the data; normal distribution, 
quantitatively measured
SD, standard deviation; SEM, standard error of the mean; Cl, 
confidence interval.
from other disciplines (27%) or healthy or community 
dwelling elderly (29%) were studied (Table 2), The 
designs of most studies were cross-sectional and 
observational. Functional, psychological and socio­
logical variables were studied in addition to biomedical 
variables. Of the 586 studies, 366 reported DMs quan­
titatively, rather than just graphically (Table 3). 
The study sample was divided into studies that 
predominantly studied biomedical, functional and 
psychological or sociological topics. Studies of func­
tional performance measures presented DM more 
often than psychological and sociological studies, 
although there were relatively few (47) in the latter 
category DM frequencies were similar.
More than 90% of the studies that presented some 
kind of DM used SD. In psychological and sociological 
studies, as well as in studies focussing on functional 
performances, it is questionable whether all variables 
m eet the precondition of being measured on interval 
or ratio scales. However, the common application of 
SD was never justified or discussed with regard to this 
precondition in any of the 586 studies. Similarly, 
normality (which is required for meaningful interpreta­
tion of SD), was only mentioned in 13 studies (2%).
ranges and CVs were reported
frequently. SDs and ranges were used in 15% of the 
w hole study sample, while just 2% used SD as well as 
percentiles. Only five studies used box-and-whisker 
plots which, along with graphical frequency distribu­
tions of dependent outcome variables in the subjects 
(used in 18 studies), show the dispersion of data 
particularly well,
DMs were discussed 30 times, but WGV in different 
age groups was discussed separately only six times.
Subjects/design No. of studies (%)
Geriatric inpatients 43 (7)
Geriatric outpatients 33 (6)
Other disciplines 161 (27)
Nursing home patients 82 (14)







Campbell and co-workers used /"-ratios to analyse age 
differences in WGV in risk factors of coronary heart 
disease between two groups aged over 70 [13]. 
Remarkably, when two groups without coronary 
heart disease were compared, the WGV was smaller 
for glucose and body mass index in subjects of 80 years 
and older than in subjects of 7 0 -7 9  years of age. No 
variables showed an increase in variability with age. 
The authors suggest that this narrower range may 
reflect better maintenance of homeostasis in the oldest 
subjects, which may be a factor in improved survival, 
Whisler and Grants found a larger WGV in the 
functioning of human B-lymphocytes in elderly 
people [14], In contrast to these two studies were 
the remaining four studies that met our criteria for 
further analysis of WGV, Hausdorff and co-workers 
focussed on measures of intra-individual walking rate 
variability [15]. They describe a larger WGV in these 
measures in the case of congestive heart failure, but did 
not find an age-related difference in WGV The groups 
of King and Baloh both discuss a larger WGV in older 
age in measures of posture and sway [16, 17]. 
Moschner and Baloh measured the effect of age on 
eye movements [18]. They found a larger WGV in the 
elderly in some, but not all variables studied. Three of 
the six studies discussing WGV measured aspects of 
posture and mobility.
The keyword ‘variability1 was mentioned four times 
in the title of this study sample. In none of these was it 
clear from the title what kind of variability had been 
studied. Twice it transpired that it was intra-individual 
variability [19, 20]. Bearden and co-workers used 
‘variability* in their title to mean the betweeivgroup 
differences in the mean number of performed cardio­
vascular imaging procedures [21]. Hausdorff at ctl. 
probably used ‘walking variability" in the title of their 
article to mean both intra-individual variability and 
WGV [15]. Another 15 studies used this keyword in the 
abstract. Three times it was used to mean intra-
<
individual variability, twice between-group variability,
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Table 3. Frequency distribution of the usage of the most important dispersion measures (DMs) lor all included 
empirical studies, and for a subdivision in three different types of outcome variables
No, (and %) of studies
DMs inclusion All (« =  586) Biomedical O =  467) Functional (n =  72) Psychol
No, of DMs
>1 366 (62) 292 (63) 55 (76) 19 (40)
0a 220 (38) 175 (37) 17 (24) 28 (60)
Type of DMs
SD 338 (58) 276 (59) 45 (63) 17 (36)
Range 122 (21) 98 (21) 19 (26) 5 (11)
Percentiles 22 (4) 16 (3) 5(7) 1 (2)
CV 6 (1) 6 (1 ) -
Other 5(1) 4 (1 ) 1 (1) -
17)
a No DMs presented numerically.
SD, standard deviation; CV, coefficient of variation.
two
another meaning. Only three times was the type of 
variability defined by the authors, In the other 12 
studies what was meant had to be determined by the 
reader from the context.
Age-effect on W G V
In 72 studies, comparisons in biomedical or functional 
variables were made between groups of subjects of 
65 years and over and subjects younger than 65 years in 
such a way that the first eight criteria for testing WGV 
were fulfilled. From these studies, 16 (23%) were 
excluded because WGV in age was unclear or more 
than twice as large in the elderly groups. Only one 
study measuring neuropsychological variables was 
excluded because of ceiling effects. The resulting 55 
studies reported on a wide range of topics within the 
field of medical gerontology (Table 4). Only two studies 
stated explicitly that data were normally distributed. To 
prevent exclusion of nearly all the studies, we assumed 
that this condition was fulfilled by all 55. The mean 
number of elderly subjects per study was 31 (range 
5-216). The mean number of younger subjects was 26 
(range 5-211). The mean ages of elderly and younger 
subjects were 75 and 30, respectively. The mean 
number of age-dependent outcome variables per study 
to be tested with F-tests was 9.6 (sum: 527; SD: 9.1, 
range: 1-46).
Vote-counting was performed for the /'-ratios of all 
included 527 variables, In most variables (54%) there 
was no significant difference in WGV between the 
elderly and the younger subjects. In the majority of the 
variables (75%) there was concordance of Fy,[V- and 7;cv~ 
tests (Table 5). In total, SDs were significantly larger for 
119 variables in the elderly. The elderly group’s CVs 
were significantly larger, smaller or not significantly 
different for 126, 51 and 350 variables, respectively. 
Thus, vote-counting indicated that there was a
percentiles of FySiv and Fcv were
considerable between-variable variability in the effect 
of age on WGV. The medians o f / ;v:u. and Fcv were 1.30 
and 1.33 respectively The distributions of 77var and 
Fcv were both skewed to the right with skewnesses of 
11.8 and 20.3, respectively (Figure 1). The 95th-
10.7 and 19.6, 
respectively. Weighted overall F-ratios were: 
Fw v;u. =  4.29; Fw cv =  7.52. These values are consider­
ably larger than the medians of the unweighed F-ratios. 
While there is no statistical test available for evaluating 
the significance of these weighted F-ratios, the critical 
F-value of 2.98 applied in vote-counting (in a case 
where the young and elderly groups had equal sample 
sizes of 10 subjects) could serve as a reference point, 
Vote-counting was also performed for each indi­
vidual study. Of the 55 studies 36% did not show a 
larger CV in WGV for any of the tested variables in the 
elderly, and 22% showed a larger CV in more than 50%
Table 4. Topics of the final study sample of 55 
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Table 5, ‘Vote counting’ for significance of 527 two-sided F-ratio tests of variances ( /y ir) and coefficients of variation 
6FCV, a  =  0.05)
No. (and %) of F-ratio tests
K m old > Fvar young Fvar old < Fv.u. young /'\1;lr non significant Total
Fcv old > Fcv young 81 (15) 10 (2) 35 (7) 126 (24)
Fcv old < Fcv young 3 (1 ) 29 (6) 19 (4) 51 (10)
Fcv 11011 significant 35(7) 31 (6) 284 (54) 350 (66)
Total 119 (23) 70 (13) 338 (64) 527 (100)
of the tested variables. A higher proportion of the 
studies (71%) did not show a smaller CV for the elderly 
in any of the variables tested, and only 4% o f the studies 
showed a significantly smaller CV for at least 50% of the 
variables tested. Hence, although there was a con­
siderable between-study variability, a larger CV was 
found for the elderly more often than a smaller CV.
Discussion
This study is the first review on dispersion measures 
in which only biomedical journals on ageing were 
selected. Moreover, our study included more articles 
than earlier reviews [7, 12, 22, 23]. Most (62%) of the 
study sample presented DMs. This is a much larger 
proportion than the 43% found by Nelson and 
Dannefer [7], possibly because far more biomedical
studies were included in our study (80% vs 44%). The 
40% of psychological and sociological studies that used 
at least one type of DMs is more consistent with their 
data. However, the overall percentage of studies in 
which DMs findings were also the subject of discussion 
is even smaller than that found by these authors (7% vs 
27%). Although the type of distribution and the type of 
measurement scale was taken into account only a few  
times, the SD is used as DMs in most studies. The SD is 
the most accurate DMs in the case of normality, but 
percentiles (and, graphically, box-and-whisker plots) 
are more informative in skewed distributions. In 
elderly populations non-normality might be common. 
However, percentiles or box-and-whisker plots were 
presented in addition to the SD in only nine and five 
studies, respectively. Studies on functional perform­
ances may frequently apply research instruments not 
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Figure 1. /^-ratios (elderly subjects/younger subjects) of variances (Fvar) and coefficients of variation ( f \ v) of S27 
biomedical variables from 55 studies on ageing. The box-plot shows: median 25th and 75th percentile and some of 
the outliers, more than 1.5 box-length from the upper edge of the box (*).
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(e.g. Mini-Mental State Examination Score, Barthel 
index). However, these type of studies mostly used 
SD. DMs probably more suitable for data with ordinal or 
nominal scales (such as the index of qualitative 
variation) were not mentioned. Despite the frequent 
presentation of DMs, few authors used the presented 
DMs in the discussion or conclusions of the article.
Age-effect on W G V
Although there is substantial evidence to support the 
hypothesis of age-related increase in WGV in geront­
ology, it remains a topic of scientific debate. Four meta­
analyses on WGV in gerontology have been published 
so far. Krauss, Devolder and Bornstein and Smircina 
examined 20, 22 and 56 articles respectively [12, 22, 
23]. Kraus supplies evidence for an increase in WGV 
with age in multiple cognitive variables, while the 
other two studies question a general increase in WGV 
with age in the fields of memory, human behaviour and 
performance. The most recent and extensive review  
was by Nelson and Dannefer [7]. In their review they 
studied 127 gerontological studies published between  
1982 and 1987 in six journals that focus on ageing and 
development. Less than half (44%) of these studies 
reported on biological variables. From the longitudinal 
and cross-sectional studies that did report these 
measures, 83 and 63% respectively showed an increase 
in the WGV for the variables that were studied. 
However, by studying the relation between age and 
WGV in reaction time, Hale et a l  showed that the 
increase in WGV was the result of the slowing of 
reaction time with age [24]. Such an increase in the 
mean might also be the explanation for increase in 
WGV in other variables. In short» there is evidence for 
an increase in WGV for many cognitive, behavioural 
and biological variables, but for other variables such an 
increase is questionable. There is limited empirical 
support to regard an increase in WGV as a universal 
consequence of ageing per sc.
In this study most of the 527 biomedical variables of 
the final study sample were studied in healthy or 
normal elderly people. Only a few studies compared 
clinical characteristics of elderly patients with those of 
younger patients with the same disease, and none of 
them described WGV of symptoms and signs quantita­
tively. Our findings give more support to a differential 
effect of ageing on WGV than to an overall increase of 
WGV with age for all kind of biomedical variables, This 
suggests that trying to study the overall effect of age on 
WGV in biomedical variables is of limited relevance. 
WGV seems to be more relevant for some studies and 
some variables than for others in comparing age 
groups. WGV may be most clearly increased by age in 
complex outcome variables such as mobility and 
posture than depend on one or more complex 
biological systems. For less complex variables, varia­
bility may or may not increase with age. The pituitary-
adrenal glucocorticoid response is an example of a less 
complex variable in which WGV showed no increase 
with age [25]. However, the immunological process of 
B-lymphocyte stimulation, also not a variable at subject 
level, showed a larger WGV in the elderly [14]. 
Although / ’-ratios were largest for variables concerning 
stability, mobility and posture, or study sample is too 
small and the between-study variability too large to 
draw conclusions on how this differential ageing 
affects WGV in different fields of medical gerontology, 
In studies with large WGV it is necessary to determine 
the factors that contribute to it. This search may 
generate valuable information about the ageing process 
itself and factors contributing to successful ageing.
The reported age-related differences in WGV in this 
review may have several explanations, Firstly, differences 
in within-subject variability between age groups may 
influence findings of WGV in cross-sectional studies, 
The effect of an increase in within-subject variability 
on WGV is mentioned explicitly by Moschner and 
Baloh [18], but may also be present in other 
studies. Secondly, WGV is highly dependent on subject 
selection. Most studies used clinical criteria such as 
medical history, physical examination, drug use and 
laboratory tests to rule out clinical and subclinical 
diseases. Six studies used the so-called SENIEIJR 
protocol, which consists of a large set of pre­
determined criteria to identify healthy elderly people 
for immunological studies [26]. In gerontological 
studies on exercise, strict criteria to include only 
healthy elderly people are developed in a similar way 
[27]. Both sets of criteria were developed to study the 
effect of age on the mean values of immunological and 
exercise variables for groups of subjects. However, 
strict criteria should also be used to study the effect of 
age per se on WGV. In our study sample, this was 
only done by Whisler and Grants in their study on 
age-related changes in functional performance of 
B-lymphocytes [14]. In contrast to such a careful 
exclusion of diseases, it seems probable that the 
general notion of increase in WGV with age is 
continuously fed by clinical observations of geriatric 
patients in the absence of exclusion criteria. Thirdly, 
ageing itself may have a differential effect on WGV in 
different variables. Whisler and (»rants support this 
view, suggesting that the ‘heterogeneity of the human 
ageing process may possibly extend to molecular 
mediators and events’ [14]. Finally, mortality may 
differentially affect the elderly populations studied. 
Different biomedical variables have different weight in 
the overall mortality risk of subjects. Hence, surviving 
may have a complex impact on WGV of study 
populations. WGV of serious risk factors may be 
decreased by surviving, as suggested by Campbell et 
al  [13], while mortality may not affect WGV in 
variables that are not risk factors.
Some caution is needed in interpreting the results 
of the / ‘-tests presented in this study. It is likely that in
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many cases the parametric /"-test will have been used 
for variables with a non-normal distribution. This may 
result in an overestimation of WGV in some studies. On 
the other hand, an underestimation of the number of 
variables with a larger WGV for the elderly is possible, 
because of the poor power of the F-tests in the case of 
small study samples. Because the five studies focussing 
on functional performances mainly measured data on 
ratio scales (e.g. time, speed, distance) it is not very 
likely that the results are seriously troubled by 
incorrect application of F-tests on data from ordinal 
measurement scales. However, the technique of vote- 
counting is possibly confounded by interdependence 
o f measures within each study. This interdependence 
could not be excluded, although only variables labelled 
as important outcome measurements were studied.
Conclusions
This study stresses the importance of reporting 
and discussing dispersion measures when publishing 
biomedical research on ageing. The quality of the 
descriptive statistics probably may be improved by 
carefully taking into account the type of measurement 
scales and the skewness or normality of the data. The 
term ‘variability’ should be used more precisely by 
adding explanatory terms, The hypothesis of a general 
increase in WGV with age in all biomedical variables is 
not supported by this review. However, clinical data on 
the topic of WGV and their discussion were sparse, 
even though only biomedical journals on ageing were 
selected. Without scientific evidence, individualized 
alternatives for the diagnostic and therapeutic manage­
ment of elderly patients are advocated in the deter­
mination of biochemical reference ranges [28], in 
pharmacotherapy [29] and in the treatment of gero- 
psychiatric disorders [30]. More data are needed to 
ensure than an expensive request for individualizing 
health care for the elderly is well-founded. In conclu­
sion, nuances in the meaning of variability must be 
clarified in future research on ageing.
Key points
• Published clinical data on within-group variability 
with age in biomedical variables are sparse.
• The term ‘variability’ should be used more precisely 
and nuances in its meaning clarified.
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